111, Inc.
YI
Rank in Stocks
#25471
Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010... Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients β comprising pharmacies and wholesalers β with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.
Share Price
$2.93
Last synced: 2026-11-09
Market Cap
$25.77M
Change (1 day)
1.00%
Change (1 year)
-28.39%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade 111, Inc. (YI)
Category
Healthcare
EPS for 111, Inc. (YI)
EPS as of June 2026 TTM: $-1.79
According to 111, Inc.'s latest financial reports, its current EPS (TTM) is $-1.79. At the end of 2025 the company had an EPS of $-1.06, a decrease compared to its 2024 EPS of $-1.03.
EPS history for 111, Inc. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-1.79 | 68.70% |
| 2025 | $-1.06 | 2.93% |
| 2024 | $-1.03 | -84.34% |
| 2023 | $-6.58 | -9.29% |
| 2022 | $-7.25 | -42.91% |
| 2021 | $-12.71 | 49.83% |
| 2020 | $-8.48 | -1.84% |
| 2019 | $-8.64 | -22.25% |
| 2018 | $-11.11 | 4.72% |
| 2017 | $-10.61 | -36.54% |
| 2016 | $-16.72 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $39.05 | -2,283.76% |
US
|
|
| $17.99 | -1,106.04% |
US
|
|
| $7.77 | -534.52% |
US
|
|
| $17.99 | -1,106.04% |
US
|
|
| $0.04 | -102.43% |
AU
|
Questions about 111, Inc.'s earnings per share (EPS)
What is 111, Inc.'s earnings per share (EPS)?
111, Inc.'s earnings per share (EPS) over the last twelve months is $-1.79, as of Jun 2026.
What was 111, Inc.'s earnings per share (EPS) in 2025?
In 2025, 111, Inc.'s earnings per share (EPS) was $-1.06, compared with $-1.03 in 2024.
How has 111, Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, 111, Inc.'s earnings per share (EPS) was highest in 2024 ($-1.03) and lowest in 2021 ($-12.71).
How does 111, Inc.'s earnings per share (EPS) compare with similar companies?
111, Inc.'s earnings per share (EPS) ($-1.79) is lower than that of all 5 similar companies listed above. The highest among them is McKesson Corporation, with $39.05.